ZTSZoetis
$74.80-49% 1Y
$74.80
$69.1152 weeks$145.76
The financials
Zoetis by the numbers
Zoetis (ZTS) reported revenue of $2.47B in Q2 2026 (quarter ended Jun 30, 2026), down 0.2% from the same quarter a year earlier. That came with a gross margin of 73% and net income of $691M (28% of revenue). For the full year FY2025, revenue was $9.47B (+2.3% year on year) and net income $2.67B. Its largest product in Q2 2026 was Dermatology at $398M, 17.5% of the disclosed total, just ahead of Cattle at 17.1%. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $2.47B | $2.47B | −0.2% |
| Gross profit | $1.79B | $1.81B | −0.8% |
| Net income | $691M | $726M | −4.8% |
| Diluted EPS | $1.65 | $1.63 | +1.2% |
| Product | Revenue | Share |
|---|---|---|
| Dermatology | $398M | 17% |
| Cattle | $390M | 17% |
| Anti Infective Products | $244M | 11% |
| Livestock | $222M | 9.8% |
| Pain Sedation | $217M | 9.5% |
| Other Pharmaceuticals | $168M | 7.4% |
| Animal Health Diagnostics | $123M | 5.4% |
| Swine | $117M | 5.1% |
| Poultry | $115M | 5.1% |
| Fish | $83M | 3.6% |
| Horses | $74M | 3.3% |
| Other Non Pharmaceuticals | $70M | 3.1% |
| Contract Manufacturingand Human Health Diagnostics | $29M | 1.3% |
| Manufactured Product Other | $26M | 1.1% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q2 2026Total $2.28B (+4.5%)
Livestock grew +23% year on yearDermatology -16% year on year
Segment Latestquarter on quarteryear on year
- Dermatology$398.0M$398.0Mquarter on quarter +14%year on year -16%+14%-16%
- Cattle$390.0M$390.0Mquarter on quarter -0.51%year on year +21%-0.51%+21%
- Anti Infective Products$244.0M$244.0Mquarter on quarter +1.2%year on year +9.9%+1.2%+9.9%
- Livestock$222.0M$222.0Mquarter on quarter -1.3%year on year +23%-1.3%+23%
- Pain Sedation$217.0M$217.0Mquarter on quarter +6.9%year on year -2.7%+6.9%-2.7%
- Other Pharmaceuticals$168.0M$168.0Mquarter on quarter +6.3%year on year -4.0%+6.3%-4.0%
- Animal Health Diagnostics$123.0M$123.0Mquarter on quarter +5.1%year on year +12%+5.1%+12%
- Swine$117.0M$117.0Mquarter on quarter -4.9%year on year -0.85%-4.9%-0.85%
- Poultry$115.0M$115.0Mquarter on quarter -2.5%year on year +11%-2.5%+11%
- Fish$83.0M$83.0Mquarter on quarter +26%year on year +2.5%+26%+2.5%
- Horses$74.0M$74.0Mquarter on quarter -2.6%year on year +4.2%-2.6%+4.2%
- Other Non Pharmaceuticals$70.0M$70.0Mquarter on quarter +6.1%year on year +2.9%+6.1%+2.9%
- Contract Manufacturing and Human Health Diagnostics$29.0M$29.0Mquarter on quarter +26%year on year -12%+26%-12%
- Manufactured Product Other$26.0M$26.0Mquarter on quarter +24%year on year +4.0%+24%+4.0%
Drug Manufacturers, Specialty & Generic
The closest names by size in the same industry